The effect of stopping smoking on cervical Langerhans'cells and lymphocytes
暂无分享,去创建一个
[1] A. Singer,et al. The antigen‐presenting environment in normal and human papillomavirus (HPV)‐related premalignant cervical epithelium , 1999, Clinical and experimental immunology.
[2] D. Eschenbach. Management of bacterial vaginosis , 1998, Drug and therapeutics bulletin.
[3] J. Collins,et al. Unique CD8+ T cell‐rich lymphoid aggregates in human uterine endometrium , 1997, Journal of leukocyte biology.
[4] A. Givan,et al. Mucosal immunity in the human female reproductive tract: cytotoxic T lymphocyte function in the cervix and vagina of premenopausal and postmenopausal women. , 1997, American journal of reproductive immunology.
[5] David R. Scott,et al. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. , 1996, Cancer research.
[6] J. Cuzick,et al. Effect of smoking cessation on cervical lesion size , 1996, The Lancet.
[7] W. Poppe,et al. Langerhans' cells and L1 antigen expression in normal and abnormal squamous epithelium of the cervical transformation zone. , 1996, Gynecologic and obstetric investigation.
[8] C. Wira,et al. Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. , 1995, Immunology.
[9] P W Hamilton,et al. Morphometry in histopathology , 1995, The Journal of pathology.
[10] A. van Assche,et al. Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. , 1995, Gynecologic and obstetric investigation.
[11] A. Ciavattini,et al. HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: integration between virus and immune system. , 1995, Gynecologic and obstetric investigation.
[12] A. Parreira,et al. Myositis with tretinoin , 1994, The Lancet.
[13] B. Rose,et al. Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease , 1994, The Lancet.
[14] D. Archer,et al. The effect of progesterone on the accumulation of leukocytes in the human endometrium. , 1994, American journal of obstetrics and gynecology.
[15] M I Shafi,et al. Digital imaging colposcopy, image analysis and quantification of the colposcopic image , 1994, British journal of obstetrics and gynaecology.
[16] X. Sun,et al. Cytokine expression in human endometrium throughout the menstrual cycle. , 1992, Human reproduction.
[17] F. Odds. Candida Infections in AIDS Patients , 1992, International journal of STD & AIDS.
[18] D. Anderson,et al. Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions. , 1992, American journal of obstetrics and gynecology.
[19] D. Jenkins,et al. CD 1a and S100 antigen expression in skin Langerhans cells in patients with breast cancer , 1991 .
[20] A. Wilson,et al. CD1a and S100 antigen expression in skin Langerhans cells in patients with breast cancer. , 1991, The Journal of pathology.
[21] C. Feyerabend,et al. A rapid gas‐liquid chromatographic method for the determination of cotinine and nicotine in biological fluids , 1990, The Journal of pharmacy and pharmacology.
[22] J. Cuzick,et al. EFFECT OF CIGARETTE SMOKING ON CERVICAL EPITHELIAL IMMUNITY: A MECHANISM FOR NEOPLASTIC CHANGE? , 1988, The Lancet.
[23] N. Benowitz,et al. Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. , 1988, American journal of public health.
[24] D. Jenkins,et al. Subpopulations of Langerhans' cells in cervical neoplasia , 1988, British journal of obstetrics and gynaecology.
[25] H. Tunstall-Pedoe,et al. Comparison of tests used to distinguish smokers from nonsmokers. , 1987, American journal of public health.
[26] D. Jenkins,et al. 3-Aminopropyltriethoxysilane (APES): a new advance in section adhesion. , 1987, Journal of clinical pathology.
[27] G. Castello,et al. Immunological abnormalities in patients with cervical carcinoma , 1987 .
[28] S. Poppema,et al. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects. , 1986, The Journal of investigative dermatology.
[29] L. Twiggs,et al. Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndrome. , 1986, American journal of obstetrics and gynecology.
[30] J. Cuzick,et al. PROGRESSIVE POTENTIAL OF MILD CERVICAL ATYPIA: PROSPECTIVE CYTOLOGICAL, COLPOSCOPIC, AND VIROLOGICAL STUDY , 1986, The Lancet.
[31] L M Cruz-Orive,et al. Estimation of surface area from vertical sections , 1986, Journal of microscopy.
[32] R. D. de Waal,et al. Immunohistochemical identification of Langerhans cells in normal epithelium and in epithelial lesions of the uterine cervix. , 1986, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[33] G. Murphy. Cell membrane glycoproteins and Langerhans cells. , 1985, Human pathology.
[34] J. Cuzick. A Wilcoxon-type test for trend. , 1985, Statistics in medicine.
[35] M. Murphy,et al. Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. , 1982, Chest.
[36] S. Hsu,et al. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[37] C. Fenoglio,et al. Reactivity of Langerhans cells with hybridoma antibody. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Repine,et al. Reversible impairment of the adherence of alveolar macrophages from cigarette smokers. , 2015, The American review of respiratory disease.
[39] M. Salkie,et al. TESTS OF LIVER FUNCTION , 1974 .